Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Paris  >  Eurofins Scientific    ERF   FR0014000MR3

EUROFINS SCIENTIFIC

(ERF)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Eurofins Scientific : Shares in France's Eurofins rally as it targets more coronavirus products

08/06/2020 | 01:45am EST

French laboratories and diagnostics company Eurofins said it hoped to launch more products aimed at detecting the presence of the coronavirus, as it posted an increase in first-half profits, sending its shares to record highs.

Net profits rose 60.9% from a year earlier to 95 million euros (85.92 million pounds).

Revenues increased 7.2% to 2.323 billion euros and Eurofins said it was confident of meeting its 2020 financial targets, which include reaching 5 billion euros of revenues.

Eurofins has launched an array of products to detect the presence of SARS-CoV-2 virus responsible for the COVID-19 disease, buoying its overall performance.

Eurofins shares were up by around 10% in early session trading, at all-time highs. The stock has risen by roughly 30% since the start of 2020, giving Eurofins a market capitalisation of around 12 billion euros.

"A strong performance across the board," wrote brokerage Jefferies, keeping a 'buy' rating on Eurofins' shares.

(Reporting by Sudip Kar-Gupta; Editing by Shri Navaratnam and Edmund Blair)

By Sudip Kar-Gupta


© Reuters 2020
All news about EUROFINS SCIENTIFIC
01/15Eurofins Launches New Test, Increased Capacity to Detect SARS-CoV-2 Variants
MT
01/15EUROFINS : the global leader in analytical testing, expands worldwide face mask ..
BU
01/15EUROFINS SCIENTIFIC : Launches New Tests and Massive Capacity for Detecting and ..
BU
01/11EUROFINS SCIENTIFIC : Anti-COVID-19 System Gets Emergency Response Validation PT..
MT
01/11EUROFINS SCIENTIFIC : GeneScan Technologies Announces AOAC PTM Accreditation for..
BU
2020EUROFINS SCIENTIFIC : Launches Full-Length COVID-19Viral Genome Sequencing Servi..
MT
2020EUROFINS SCIENTIFIC : Genomics Launches Cost-Effective SARS-CoV-2 full-length Vi..
BU
2020EUROFINS CEREP : Launches PCR COVID-19 Self-Test In Germany, Spain
MT
2020EUROFINS SCIENTIFIC : launches COVID-19 PCR tests with at-home self-sampling opt..
PU
2020EUROFINS SCIENTIFIC : Lifts FY20 Revenue, Profit Outlook On Strong Trading, Orga..
MT
More news
Financials
Sales 2020 5 265 M 6 357 M 6 357 M
Net income 2020 391 M 473 M 473 M
Net Debt 2020 2 866 M 3 460 M 3 460 M
P/E ratio 2020 34,7x
Yield 2020 0,67%
Capitalization 14 262 M 17 243 M 17 221 M
EV / Sales 2020 3,25x
EV / Sales 2021 3,01x
Nbr of Employees 48 000
Free-Float 66,7%
Chart EUROFINS SCIENTIFIC
Duration : Period :
Eurofins Scientific Technical Analysis Chart | ERF | FR0014000MR3 | MarketScreener
Technical analysis trends EUROFINS SCIENTIFIC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 73,55 €
Last Close Price 74,75 €
Spread / Highest target 13,8%
Spread / Average Target -1,60%
Spread / Lowest Target -48,9%
EPS Revisions
Managers and Directors
NameTitle
Gilles J. Martin Chairman & Chief Executive Officer
Laurent Lebras Director-Group Finance & Administration
Andreas König Chief Information Officer
Yves-Loïc Martin Non-Executive Director
Valérie Hanote Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
EUROFINS SCIENTIFIC8.92%17 243
SQUARE, INC.4.65%102 701
FISERV, INC.-4.97%72 541
GLOBAL PAYMENTS INC.-11.16%57 287
CINTAS CORPORATION-7.75%34 247
OFFCN EDUCATION TECHNOLOGY CO., LTD.-5.21%31 695